Bezafibrate

Records for this ingredient, by country (identity only).

ATC C10AB02 · 10 markets · 104 records

Bezafibrate 10 markets · 104 records Forms
Filters

GB 38 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

  • 200 mgtabletBezalip 200mg tabletsManufacturer: A A H Pharmaceuticals Ltd、Manufacturer: Actavis UK Ltd、Manufacturer: Alliance Healthcare (Distri…、Manufacturer: DE Pharmaceuticals、Manufacturer: Dowelhurst Ltd、Manufacturer: Kent Pharma (UK) Ltd、Manufacturer: Mawdsley-Brooks & Company L…、Manufacturer: Noumed Life Sciences Ltd +5 also in CN·TW·JP
    +4Other 4 marketsESFRSGMX
  • 400 mgtablet · extended-releaseBezagen XL 400mg tabletsBezalip Mono 400mg modified-release tablets、Fibrazate XL 400mg tablets、Liparol 400 XL tablets、Lipozate 400mg modified-release tablets、Zimbacol XL 400mg tablets、Manufacturer: A A H Pharmaceuticals Ltd、Manufacturer: Alliance Healthcare (Distri…、Manufacturer: DE Pharmaceuticals +4 also in CN·CA·ES
    +1Other 1 marketsFR
  • 200 mg/5 mLliquidManufacturer: Special Order

CN 18 records · 3 shown of 3 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 200 mgtablet益之特苯扎贝特阿贝他、Manufacturer: 江苏万高药业股份有限公司、Manufacturer: 江苏康缘药业股份有限公司、Manufacturer: 浙江亚太药业股份有限公司、Manufacturer: 黑龙江天宏药业股份有限公司 also in GB·TW·JP
    +4Other 4 marketsESFRSGMX
  • 400 mgtablet · extended-releaseManufacturer: 江苏天士力帝益药业有限公司 ×2 also in GB·CA·ES
    +1Other 1 marketsFR
  • 200 mgcapsuleManufacturer: 南通久和药业有限公司 ×3

TW 14 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

  • 200 mgtablet"井田" 暢脂膜衣錠200公絲(本那非泊)"國嘉"濾脂清膜衣錠200毫克(本那非泊)、"應元"必濾脂錠200毫克(本那非泊)、"生達"必克脂膜衣錠200公絲(本那非泊)、"華盛頓" 優平錠200公絲(本那非泊)、"華興"利脂落膜衣錠200公絲(本那非泊)、"黃氏"克脂清錠200毫克(本那非泊)、ANTIFAT TABLETS 200MG (BEZAFIBRATE) "ASTAR"、BEFAT F.C. TAB. 200MG "STANDARD"(BEZAFIBRATE) +17 also in GB·CN·JP
    +4Other 4 marketsESFRSGMX
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名"元宙"費洛脂錠 ×1Fizate Tablets "Y.C." ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 4 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名BEZALIP RETARD ×2ZAFIBRAL TABLET 200 mg ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

  • 200 mgtabletBEFIZAL 200 mg, comprimé pelliculé also in GB·CN·TW
    +4Other 4 marketsJPESSGMX
  • 400 mgtablet · extended-releaseBEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongée also in GB·CN·CA
    +1Other 1 marketsES

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

MX 1 records · 1 shown of 1 Source COFEPRIS · Data as of annual

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.